Nasdaq Moves to Delist ClearOne Over $2.5M Equity Shortfall
CLRO sits 42% above its 52-week low of $2.71.
Summary
Nasdaq has determined to delist ClearOne for failing to meet the $2.5 million minimum stockholders' equity requirement. The company will appeal, but trading could be suspended as early as October 19, 2026.
Key Events · Legal and Risk Events · CLRO
-
Nasdaq Delisting Determination
On October 8, 2026, Nasdaq Staff determined to delist ClearOne's securities for failure to meet the $2,500,000 minimum stockholders' equity requirement under Rule 5550(b)(1).
-
Appeal and Stay
ClearOne intends to request a hearing before a Nasdaq Hearings Panel by October 15, 2026, which would automatically stay any suspension or delisting action pending the hearing and any extension period granted.
-
Trading Suspension Deadline
Unless the company timely requests a hearing, trading in ClearOne common stock will be suspended at the opening of business on October 19, 2026.
-
Compliance Plan Failed
Nasdaq determined the company had not completed the remedial actions contemplated by the compliance plan submitted on May 22, 2026, following the original April 7, 2026 deficiency notice.
Analysis · CLRO · Manufacturing
ClearOne received a Nasdaq Staff determination letter on October 8, 2026, ordering delisting from The Nasdaq Capital Market because the company failed to meet the $2,500,000 minimum stockholders' equity requirement under Rule 5550(b)(1). The company plans to request a hearing by October 15, 2026, which would automatically stay the delisting pending the panel's decision. If no hearing is requested, trading halts on October 19, 2026. This is a critical liquidity event: delisting would likely force institutional selling, reduce access to capital, and compound the company's already distressed state — the Q1 2026 10-Q disclosed a going concern warning and Nasdaq delisting risk, and the company has been pursuing a reverse merger with Cortigent and a $15 million unit offering to shore up its balance sheet. The delisting determination directly threatens those efforts.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 45.6% of the 241 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLRO was trading at $3.85 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $11M. The 52-week trading range was $2.71 to $16.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.